Search Results

1 - 10 of 73 items :

  • Central Europe x
  • Haematology, Oncology x
Clear All
Health-related quality of life in Croatian general population and multiple myeloma patients assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 questionnaires

on comparable and standardized measures and that can be used to improve the health care system. Conducting studies using various health-related quality of life measures is a basis for improvement of health care delivery. 6 In the last decades, the measurement of health-related quality of life has gained acceptance as a primary or secondary endpoint in cancer research worldwide. 7 Evaluation of quality of life is conducted by using standardized questionnaires. 8 European Organization for Research and Treatment of Cancer (EORTC) has purposed a development of an

Open access
Multigene expression signatures in early hormone receptor positive HER 2 negative breast cancer

as to the lymph node status. 2 , 8 All multigene signatures are recommended for use in HR+HER2- lymph node negative or positive BC by the European Group on Tumor Markers (EGTM), except for BCI. 6 Oncotype DX is the only multigene signature assigned with NCCN category of preference as preferred in lymph node negative patients (category 1 evidence) and is the only signature with predictive value, MammaPrint has category 1 recommendation as prognostic for lymph node negative and positive patients. 9 ASCO guidelines strongly recommend the use of Oncotype DX and

Open access
Advances in the management of craniopharyngioma in children and adults

) deficiency follow in decreasing order. Central diabetes insipidus resulting from anti-diuretic hormone (ADH) deficiency occurs almost twice more frequently in children than in adults, can be transient after the procedure and it persists in 65–96% of childhood-onset CP subjects. 8 , 18 , 21 Substitution therapy with hr-GH is safe, effective and does not affect relapse and progression rates. 67 In patients with GH substitution, a better QoL has been reported. 11 In children after the surgery, despite their GH deficiency, a normal or accelerated growth pattern has been

Open access
Radiological findings of porcine liver after electrochemotherapy with bleomycin

irreversible electroporation (IRE) ablation and electrochemotherapy (ECT), are advantageous for patients with unresectable hepatic neoplasia adjacent to major bile ducts and vessels. 1 , 2 , 3 , 5 ECT is a method for the delivery of chemotherapeutic drugs by reversible electroporation, which enables the entry of otherwise poorly or nonpermeant exogenous molecules into cells by the application of short high-intensity electric pulses that induce reversible cell membrane permeabilization. 6 , 7 , 8 ECT is nowadays widely used in European centers for the treatment of

Open access
The multidisciplinary team for gastroenteropancreatic neuroendocrine tumours: the radiologist’s challenge

neuroendocrine tumour and the availability of specialized imaging techniques and expertise. 8 Figure 1 A 45 yrs old female: CEUS study of inhomogeneous pancreatic lesion (A) , with necrotic central area (arrow). CT (B) , during late arterial phase of contrast study shows the same vascular profile (arrow) seeing during CEUS study. Anatomical and functional imaging Imaging modalities can be anatomic, which assess the physical characteristics of the tissue, or functional, which assess the biochemical characteristics. 7 The increase of knowledge about these

Open access
ABC of viral infections in hematology: focus on herpesviruses

Brain MRI often normal No Additional methods DNA-emia (PCR) DNA-emia (PCR) DNA-emia (PCR) Clinical + PCR p/s (plasma/serum); PET (positron emission tomography); CNS (central nervous system); other abbreviations in text . Wu et al. [ 18 ] also analyzed the incidence of viral CNS reactivation of herpesviruses, with overall incidence of 12.4%. The most frequent were as follows: EBV, 57.1%; HSV1, 19.0%; CMV, 14.3%; VZV, 4.8%, and mixed 4.8% (EBV+CMV). Polish analyses [ 19 , 20 , 21 ] showed the incidence of viral reactivation in

Open access
Infectious complications in children and adults with hematological malignancies

Introduction: nationwide project Infections are the main cause of morbidity and mortality in patients with cancer or undergoing stem cell transplantation [ 1 ]. Children and adults with hematologic malignancies are especially susceptible to bacterial, fungal, and viral infections due to abnormality of the basic mediators of immunity. Factors that predispose these patients to infection include the following: alterations of the body’s natural barriers, presence of central venous catheters, alteration of the innate immune system and acquired immunity, as well as

Open access
Diagnosis and management of complications of chronic lymphocytic leukemia/small lymphocytic lymphoma

Introduction Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) is the most prevalent lymphoid malignancy in Europe [ 1 ] and North America [ 2 ] and causes considerable morbidity and mortality. CLL is associated with early onset and often profound immune dysregulation that increases the risk of infection, second malignancies, and autoimmune complications [ 3 , 4 , 5 ]. The incidence and prevalence of these complications are likely to increase because of population aging and the ongoing development of more effective but still noncurative

Open access
Targeting the PD-1/PD-L1 axis in the treatment of lung cancer

with ipilimumab for the second line treatment of advanced NSCLC and for pretreated advanced renal cancer [ 13 ]. The European Medicines Agency (EMA) has approved the agent for advanced melanoma and advanced squamous NSCLC after prior chemotherapy [ 14 ]. Although multiple regimens have been evaluated in clinical trials, the approved dose is 3 mg/kg, administered intravenously every 2 weeks. The activity of nivolumab in advanced NSCLC was first demonstrated in a phase I trial, where in a cohort of 129 pretreated patients, of whom more than half had received at least

Open access
BRCA1/2 associated cancer susceptibility: a clinical overview

primary breast 3.5% within 5 years Up to 11% 27% within 5 yrs 12% within 5 yrs 40%-50% at 20 yrs Ovarian 1%-2% 24%-40% 11%-18% Male breast 0.1% 1%-2% 5%-10% Prostate 15% (N. European origin) 18% (African Americans) <30% <39% Pancreatic 0.50% 1%-3% 2%-7% There is an increasing evidence that subsequent generations of mutations carriers tend to develop malignancies at younger ages, supporting the existence of genetic anticipation in BRCA1/2 inheritance. Cancers tend to be diagnosed at ages 7–8 years younger

Open access